3PBIOVIAN

Executive Summary

3PBIOVIAN is a private Contract Development and Manufacturing Organization (CDMO) specializing in biologics and biopharmaceuticals, with end-to-end capabilities from early-stage process development through commercial-scale cGMP manufacturing. Headquartered in Turku, Finland, and with operations in Pamplona-Noáin, Spain, the company serves the growing demand for outsourced biologics production, particularly antibodies. Despite being in the pre-clinical stage, 3PBIOVIAN's facilities are positioned to support clients in advancing their drug candidates to the clinic and beyond. The CDMO market is experiencing robust growth, driven by the expansion of biologics pipelines and the need for flexible manufacturing solutions. 3PBIOVIAN differentiates itself through its integrated service model and European presence. As a private company with limited public disclosures, its near-term outlook hinges on securing new client contracts and expanding capacity. The company's ability to navigate the competitive landscape and demonstrate reliability will be key to its success.

Upcoming Catalysts (preview)

• Q3 2026Expansion of commercial-scale cGMP capacity at Turku facility70% success
• TBDWin of a major client contract for antibody manufacturing60% success
• Q4 2026Completion of process development platform upgrade for enhanced yield85% success